CrashFix crashes browsers to coerce users into executing commands that deploy a Python RAT, abusing finger.exe and portable Python to evade detection and persist on high‑value systems.

Rachel Bloor found a reptile in her bed on Monday In the middle of the night on Monday, Rachel Bloor stirred in her bed to find a heavy weight curled up on her chest. Half asleep, she reached out for ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. If you read my article here, you will already know that ...

It's difficult to put an exact price tag on how much index funds have saved investors since their creation in 1975. But it's safe to say it's a big number. It's also safe to say that the savings ...

Google is rolling out the latest Find Hub app update on Android, while android.com now offers a comprehensive list of compatible devices. Version 3.1.458 of Find Hub is rolling out with a pair of ...

Peter Waldman Artisan, glassblower, and balloon man. Peter Waldman is never without a balloon. Even out to dinner, he will pause and twist up a creation if there’s a child nearby. For the past 40 ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Python maintains its runaway top ranking in the Tiobe index of programming language popularity, while older languages continue to rise. Perl surprises. Python, the highest-ranking language ever in the ...

Replimune (NASDAQ:REPL) climbed more than 100% on Wednesday as Cantor Fitzgerald upgraded the cancer drug developer, citing a potential reversal of an FDA decision that rejected its lead drug ...

Despite a sharp drop in the previous session following the FDA rejection of its skin cancer drug RP1, Replimune (NASDAQ:REPL) shares bounced back on Wednesday even as multiple Wall Street analysts ...

NEW YORK--(BUSINESS WIRE)--Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Replimune Group, Inc. (NASDAQ: REPL) for potential violations of the federal ...